| Q46831959 | A disk-diffusion-based target identification platform for antibacterials (TIPA): an inducible assay for profiling MOAs of antibacterial compounds |
| Q24649944 | A model for glutathione binding and activation in the fosfomycin resistance protein, FosA |
| Q27642065 | A new view of the mechanisms of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate-3-phosphate synthase (AroA) derived from X-ray structures of their tetrahedral reaction intermediate states |
| Q42647502 | A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA). |
| Q88906095 | Adaptation to the coupling of glycolysis to toxic methylglyoxal production in tpiA deletion strains of Escherichia coli requires synchronized and counterintuitive genetic changes |
| Q30834642 | An array of target-specific screening strains for antibacterial discovery |
| Q39556778 | Antibiotic susceptibility of enterohemorrhagic Escherichia coli O157:H7 isolated from an outbreak in Japan in 1996. |
| Q28547100 | Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China |
| Q37311884 | Biosynthesis of phosphonic and phosphinic acid natural products. |
| Q40476281 | Blocking peptidoglycan recycling in Pseudomonas aeruginosa attenuates intrinsic resistance to fosfomycin. |
| Q37706217 | Cell wall precursors are required to organize the chlamydial division septum. |
| Q33793074 | Challenges of antibacterial discovery |
| Q43871900 | Characterization and inhibition study of MurA enzyme by capillary electrophoresis |
| Q30895039 | Combinatorial enzymatic assay for the screening of a new class of bacterial cell wall inhibitors |
| Q36702923 | Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis |
| Q38420842 | Comprehensive structural and functional characterization of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (Mtb-MurA) and prediction of its accurate binding affinities with inhibitors |
| Q33840373 | Covalent modification as a strategy to block protein-protein interactions with small-molecule drugs |
| Q27733409 | Crystal structure of UDP-N-acetylglucosamine enolpyruvyltransferase, the target of the antibiotic fosfomycin |
| Q37081699 | Cytoplasmic steps of peptidoglycan biosynthesis |
| Q37835599 | Deconstructing the Chlamydial Cell Wall |
| Q44555560 | Determination of phosphate in nanomolar range by an enzyme-coupling fluorescent method |
| Q37335513 | Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis |
| Q39651496 | Development of a whole-cell assay for peptidoglycan biosynthesis inhibitors |
| Q36175676 | Differential antibacterial properties of the MurA inhibitors terreic acid and fosfomycin |
| Q37866109 | Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release |
| Q34163009 | Evidence that the fosfomycin-producing epoxidase, HppE, is a non-heme-iron peroxidase |
| Q52895876 | Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway. |
| Q39071416 | Fosfomycin: Mechanism and Resistance |
| Q47136072 | Fosfomycin: Pharmacological, Clinical and Future Perspectives. |
| Q36803694 | Fosfomycin: Resurgence of an old companion. |
| Q37957839 | Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. |
| Q64116187 | Fosfomycin: the characteristics, activity, and use in critical care |
| Q27677546 | Functional Consequence of Covalent Reaction of Phosphoenolpyruvate with UDP-N-acetylglucosamine 1-Carboxyvinyltransferase (MurA) |
| Q37451542 | Functional and biochemical analysis of the Chlamydia trachomatis ligase MurE. |
| Q26864667 | Genomics-enabled discovery of phosphonate natural products and their biosynthetic pathways |
| Q42650271 | High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium. |
| Q31016009 | Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme |
| Q33416937 | Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli |
| Q34473355 | Identification of a novel fosfomycin-resistant UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from a soil metagenome |
| Q41597001 | Identification of a second two-component signal transduction system that controls fosfomycin tolerance and glycerol-3-phosphate uptake |
| Q41488457 | Identification of cellular targets of a series of boron heterocycles using TIPA II-A sensitive target identification platform |
| Q48022320 | Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB. |
| Q34514901 | In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance |
| Q43190887 | Inhibitory mechanism of the Qβ lysis protein A2. |
| Q24675383 | Initiating a crystallographic analysis of recombinant (S)-2-hydroxypropylphosphonic acid epoxidase from Streptomyces wedmorensis |
| Q43821664 | Mechanism-based inhibition of enzyme I of the Escherichia coli phosphotransferase system. Cysteine 502 is an essential residue |
| Q36490822 | Molecular Basis for Resistance Against Phosphonate Antibiotics and Herbicides |
| Q26853135 | Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance |
| Q36679193 | Multi-targeting by monotherapeutic antibacterials. |
| Q33707109 | Mutations of the Transporter Proteins GlpT and UhpT Confer Fosfomycin Resistance in Staphylococcus aureus |
| Q38782638 | Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target |
| Q91807571 | New tuberculosis drug targets, their inhibitors, and potential therapeutic impact |
| Q99590699 | Organoarsenicals inhibit bacterial peptidoglycan biosynthesis by targeting the essential enzyme MurA |
| Q37810971 | Peptidoglycan biosynthesis machinery: a rich source of drug targets |
| Q38113689 | Prospects for new antibiotics: a molecule-centered perspective |
| Q33710466 | Recruitment of genes and enzymes conferring resistance to the nonnatural toxin bromoacetate |
| Q64249427 | Revisiting Anti-tuberculosis Therapeutic Strategies That Target the Peptidoglycan Structure and Synthesis |
| Q41908390 | Role of the CpxAR two-component signal transduction system in control of fosfomycin resistance and carbon substrate uptake |
| Q27670812 | Structural and Functional Characterization of NikO, an Enolpyruvyl Transferase Essential in Nikkomycin Biosynthesis |
| Q36319020 | Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development. |
| Q27734363 | Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin |
| Q27660525 | The Fungal Product Terreic Acid Is a Covalent Inhibitor of the Bacterial Cell Wall Biosynthetic Enzyme UDP- N -Acetylglucosamine 1-Carboxyvinyltransferase (MurA), |
| Q38394431 | The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan |
| Q34568935 | The bacterial cell wall as a source of antibacterial targets |
| Q26824482 | The structural biology of enzymes involved in natural product glycosylation |
| Q35428115 | Tunable protein degradation in bacteria |
| Q33601835 | Two active forms of UDP-N-acetylglucosamine enolpyruvyl transferase in gram-positive bacteria |
| Q37913126 | UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments |
| Q42323107 | Ultrasensitive regulation of anapleurosis via allosteric activation of PEP carboxylase |
| Q36683661 | Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic Aspects |
| Q74578961 | Uptake of [3H]-fosfomycin into cells of enterohemorrhagic Escherichia coli O157 and E. coli non-O157 |
| Q40339642 | fosI Is a New Integron-Associated Gene Cassette Encoding Reduced Susceptibility to Fosfomycin |